Browsing: Health

The European Commission has expanded its Ebola response with a €2.1 million purchase of PCR tests for the Bundibugyo virus outbreak. Shipments are due to start in August as health teams confront a large outbreak centered in the Democratic Republic of the Congo and affecting parts of the wider region. PCR testing allows laboratories to confirm infections and support surveillance around known cases. The latest supply package adds laboratory resources at a time when authorities continue to monitor transmission across several provinces and health zones in the Democratic Republic of the Congo.

Australian researchers from Adelaide University and the Olivia Newton-John Cancer Research Institute have identified a novel molecular switch that drives the spread of aggressive tumors. Published in EMBO Molecular Medicine, the breakthrough study reveals that Australian researchers uncover a promising new way to tackle triple-negative breast cancer by restoring a critical regulatory molecule known as miR-342. The discovery opens new avenues to prevent life-threatening secondary cancers in organs such as the lungs and bones. Triple-negative breast cancer accounts for 10% to 15% of Australia’s approximately 21,000 annual breast cancer diagnoses but causes a disproportionate number of deaths. Lead investigators demonstrated that when miR-342 levels fall, a cancer-driving pathway called E2F becomes overactive, allowing dormant cancer cells to spread throughout the body and form dangerous secondary tumors. In pre-clinical models, scientists demonstrated that restoring miR-342 levels markedly reduced the spread of cancer cells to distant organs. Furthermore, researchers discovered that palbociclib, an existing CDK4/6 inhibitor drug currently approved for hormone receptor-positive breast cancers, significantly halted metastatic tumor growth in models exhibiting low miR-342 levels. The findings suggest measuring miR-342 levels could allow doctors to repurpose existing therapeutics to treat high-risk patients. Co-senior author Associate Professor Philip Gregory from Adelaide University’s Centre for Cancer Biology confirmed that preventing metastasis remains the primary challenge in treating aggressive breast cancers. Gregory emphasized that because palbociclib targets the overactive E

The Democratic Republic of the Congo will receive 70,000 Ervebo Ebola vaccine doses as the Bundibugyo outbreak expands. Congolese authorities reported 5,208 confirmed cases and 2,476 deaths as of Aug. 18. The outbreak now affects 56 health zones across six provinces in the east and northeast. Authorities also listed 1,115 recoveries, while 730 patients remained in isolation or hospital care.

WHO incident manager Thierno Baldé said the three-month timeline depends on securing the resources required for the response. The agency has received about $69.3 million of the $115 million it says it needs, or roughly 60%. Teams added more than 400 treatment beds during the past two weeks. They also deployed 100 additional epidemiologists and more than 500 community health workers for surveillance and contact tracing. The response requires vehicles, ambulances, medical supplies and personnel across a growing affected area.

The Democratic Republic of the Congo recorded 26,064,143 malaria cases in 2025. The country also reported 29,938 deaths linked to the disease during the year. Guy Esebe Dembo, deputy director of the National Malaria Control Programme, announced the figures during a campaign launch in Ituri province. Dembo said malaria remains the country’s main public health challenge. The new totals confirm a heavy disease burden across one of Africa’s most malaria-affected countries.

DR Congo’s Ebola outbreak has killed 1,916 people and produced 4,209 confirmed cases, according to official data through Aug. 7. That raises the death toll 29 above the 1,887 figure reported in the earlier update. Health authorities also counted 595 patients receiving care in isolation. Another 828 people have recovered from the Bundibugyo virus disease outbreak.

Obesity was linked to 9,509 deaths in Belgium during 2022, representing 8.2 percent of total national mortality, according to new data from the Belgian public health institute Sciensano. Marking the first time public health researchers in the country have systematically quantified mortality directly attributable to an elevated body mass index (BMI), the report reveals that weight-related complications caused more than one death per hour nationwide. The statistical findings also show that high BMI resulted in over 150,000 lost years of life across all demographic groups in a single year.

Moderna has started a Phase 1 trial of an experimental vaccine against Bundibugyo ebolavirus in Canada. The first participant received the mRNA-1469 vaccine on August 3 at a site in Truro, Nova Scotia. The trial comes as the virus continues spreading across several provinces in the Democratic Republic of the Congo. The World Health Organization has classified the outbreak as a public health emergency of international concern.

Michigan health officials have confirmed two deaths connected to the state’s 2026 cyclosporiasis outbreak. The Michigan Department of Health and Human Services reported 11,234 cases as of Aug. 3. The state also recorded 193 hospitalizations through July 30. Both patients had serious underlying medical conditions. Officials said cyclosporiasis and dehydration may have affected those conditions, but they released no additional personal information.

The Ebola outbreak in DR Congo has become the country’s largest recorded epidemic, with 3,605 confirmed cases and 1,587 deaths. The surge placed pressure on surveillance, treatment, and community response operations as cases span 49 health zones in five affected provinces. Health authorities continue to strengthen laboratory testing, patient care, and infection controls to curb the spread of the virus.